HFA Premium Access

Ambulatory milrinone use in an advanced heart failure unit: a useful option.

Congress Session

About the speaker

Mr Jose Maria Vieitez Florez

Puerta de Hierro Majadahonda University Hospital, Majadahonda, Madrid (Spain)
0 follower

35 more presentations in this session

Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: A post-hoc analysis from the REWIND randomized trial

Speaker: Professor K. Branch (Seattle, US)


Prognostic value of pulse pressure in heart failure with preserved ejection fraction: findings from the RICA registry

Speaker: Doctor I. Bravo Candela (Sevilla, ES)


Repetitive ambulatory doses of levosimendan for patients as bridge to heart transplant. Findings from the LEVO-T registry.

Speaker: Doctor J. De Juan Baguda (Madrid, ES)


Sacubitril/valsartan use patterns among older adults with heart failure in routine care: a US population-based cohort study of >25,000 medicare beneficiaries

Speaker: Doctor A. Bhatt (Boston, US)


Efficacy of sodium glucose cotransporter-2 inhibitors for heart failure with preserved and with mildly reduced ejection fraction: a systematic review and meta-analysis

Speaker: Doctor R. Cordovez (Cebu City, PH)


Access the full session

Heart Failure ePosters - focus on Chronic Heart Failure 3

Speakers: Mr J. Vieitez Florez, Professor K. Branch, Doctor I. Bravo Candela, Doctor J. De Juan Baguda, Doctor A. Bhatt...

About the event


Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Related content

Open Access

GUIDE-HF - Panel discussion.

27 August 2021

ESC Premium Access

An asymptomatic patient with positive treadmill test during screening for life insurance and significant proximal LAD disease in coronary CT angiography: what do the guidelines say?

27 August 2021

ESC Premium Access

Ablation or amiodarone for HFrEF patients with atrial fibrillation?

27 August 2021

This platform is supported by

logo Novo Nordisk